Abstract

Albumin is the main protein of blood plasma, lymph, cerebrospinal and interstitial fluid. The protein participates in a variety of important biological functions, such as maintenance of proper colloidal osmotic pressure, transport of important metabolites and antioxidant action. Synthesis of albumin takes place mainly in the liver, and its catabolism occurs mostly in vascular endothelium of muscle, skin and liver, as well as in the kidney tubular epithelium. Long-lasting investigation in this area has delineated the principal route of its catabolism involving glomerular filtration, tubular endocytic uptake via the multiligand scavenger receptor tandem—megalin and cubilin-amnionless complex, as well as lysosomal degradation to amino acids. However, the research of the last few decades indicates that also additional mechanisms may operate in this process to some extent. Direct uptake of albumin in glomerular podocytes via receptor for crystallizable region of immunoglobulins (neonatal FC receptor) was demonstrated. Additionally, luminal recycling of short peptides into the bloodstream and/or back into tubular lumen or transcytosis of whole molecules was suggested. The article discusses the molecular aspects of these processes and presents the major findings and controversies arising in the light of the research concerning the last decade. Their better characterization is essential for further research into pathophysiology of proteinuric renal failure and development of effective therapeutic strategies.

Highlights

  • Albumin is one of the earliest recognized proteins in the body

  • The main role of CUBAM in tubular albumin uptake was demonstrated in recent studies in mice with renal-specific knockout of cubilin and megalin, in which moderate tubular albuminuria was observed [54,72]

  • FcRn binds albumin, which is released from its receptors, presumably the megalin/cubilin complex in the acidic endosome environment, and is directed through transcytosis to the basal site of tubular epithelial cells, where it is released into the interstitial tissue as a consequence of increasing pH [85]

Read more

Summary

Introduction

Albumin is one of the earliest recognized proteins in the body. It was first described by Denis in 1840. Its name derives from the Latin word albus (white) due to the property of white precipitate formation in an acidic environment This protein is very common in the body, and is present in inter alia: plasma, lymph, cerebrospinal and extracellular fluid. A decrease in albumin concentration is observed in many metabolic disorders of various etiologies It may be the result of: improper distribution for example at pancreatitis, reduced synthesis in liver cirrhosis, amino acid absorption disorders or low-protein diets; loss in the course of enteropathy, burns, surgical procedures or nephrotic syndrome, as well as accelerated catabolism in inflammation and cancer. The study presents the results of the latest research in this field

Synthesis
Catabolism
Renal Albumin Catabolism
Glomerular Filtration of Albumin
Albumin Reabsorption
Cubilin
Megalin
Neonatal Fc Receptor of Immunoglobulin Fragment
Transport to Lysosomes and Degradation
Lysosomal Degradation
Transcytosis
Conclusions
Findings
Perspectives
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call